Chikungunya Virus in 2025: Epidemiology, Immunopathogenesis, and Vaccine Development — A Narrative Review
Infection and Drug Resistance · 2026-01 · Volume 19 · 1-14
DOI: 10.2147/idr.s567134 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infection and Drug Resistance, 2026-01. Verfasst von Chenxi Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing,…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China.
ORCID-Profile: Zhihai Chen
Zitieren
APA
Zhao, C., Ge, Z., Zhang, T., Jiang, Z., Tian, D., & Chen, Z. (2026). Chikungunya Virus in 2025: Epidemiology, Immunopathogenesis, and Vaccine Development — A Narrative Review. Infection and Drug Resistance, Volume 19, 1-14. https://doi.org/10.2147/idr.s567134
Vancouver
Zhao C, Ge Z, Zhang T, Jiang Z, Tian D, Chen Z. Chikungunya Virus in 2025: Epidemiology, Immunopathogenesis, and Vaccine Development — A Narrative Review. Infection and Drug Resistance. 2026;Volume 19:1-14. doi:10.2147/idr.s567134
BibTeX
@article{Zhao2026,
author = {Zhao, Chenxi and Ge, Ziruo and Zhang, Tingyu and Jiang, Zhouling and Tian, Di and Chen, Zhihai},
title = {Chikungunya Virus in 2025: Epidemiology, Immunopathogenesis, and Vaccine Development — A Narrative Review},
journal = {Infection and Drug Resistance},
year = {2026},
volume = {Volume 19},
pages = {1--14},
doi = {10.2147/idr.s567134}
}
EUVIMED